The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Incyte
Speakers' Bureau - Incyte; Kite/Gilead
Interim analysis of ZUMA-5: A phase II study of axicabtagene ciloleucel (axi-cel) in patients (pts) with relapsed/refractory indolent non-Hodgkin lymphoma (R/R iNHL).
 
Caron A. Jacobson
Honoraria - Celgene; Humanigen; Kite/Gilead; Nkarta; Novartis; Precision Biosciences
Consulting or Advisory Role - Celgene; Humanigen; Kite/Gilead; Nkarta; Novartis; Precision Biosciences
Speakers' Bureau - Axis Pharma; Clinical Care Options
Research Funding - Kite/Gilead; Pfizer
Travel, Accommodations, Expenses - Celgene; Kite/Gilead; Novartis; Precision Biosciences
 
Julio C. Chavez
Consulting or Advisory Role - Bayer; Celgene; Juno Therapeutics; Karyopharm Therapeutics; Kite/Gilead; MorphoSys; Novartis; Pfizer; TeneoBio; Verastem
Speakers' Bureau - AstraZeneca; BeiGene; Genentech; Kite/Gilead
Research Funding - Merck (Inst)
 
Alison R. Sehgal
Research Funding - Juno Therapeutics; Kite/Gilead; Merck
 
Basem M. William
Consulting or Advisory Role - Celgene; Guidepoint Global; Kyowa Hakko Kirin; miRagen; Navicor; Triangle Insights Group
Research Funding - Dova Pharmaceuticals; Incyte; Innate Pharma; Kite/Gilead; Merck; miRagen
 
Javier Munoz
Honoraria - Kyowa Hakko Kirin; Seagen
Consulting or Advisory Role - Alexion Pharmaceuticals; Bayer; BeiGene; Bristol-Myers Squibb; Celgene; Fosun Kite; Genentech; Gilead Sciences; Innovent Biologics; Janssen; Juno Therapeutics; Kite, a Gilead company; Kyowa Hakko Kirin; Pfizer; Pharmacyclics; Seagen
Speakers' Bureau - Abbvie/Genentech; Acrotech Biopharma; AstraZeneca; Bayer; BeiGene; BeiGene; Celgene; Gilead Sciences; Kite, a Gilead company; Kyowa Hakko Kirin; Pharmacyclics/Janssen; Seagen; Verastem
Research Funding - Celgene; Genentech/Abbvie; Incyte; Kite, a Gilead company; Millennium; Pharmacyclics/Janssen; Portola Pharmaceuticals; Seagen
 
Gilles A. Salles
Honoraria - Abbvie; Amgen; Autolus; Celgene; Gilead Sciences; Janssen; Merck; MorphoSys; Novartis; Roche/Genentech; SERVIER; Takeda
Consulting or Advisory Role - Acerta Pharma; Celgene; Epizyme; Gilead Sciences; Janssen; Kite, a Gilead company; Merck; morphosys; Novartis; Pfizer; Roche/Genentech; SERVIER
 
Carla Casulo
Honoraria - Gilead Sciences
Research Funding - Celgene (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Roche
 
Pashna N. Munshi
No Relationships to Disclose
 
David G. Maloney
Consulting or Advisory Role - Celgene; Eureka Therapeutics; Genentech/Roche; Gilead Sciences; Kite, a Gilead company; Novartis
Research Funding - Celgene (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst)
Patents, Royalties, Other Intellectual Property - Inventor on 4 provisional patents.
 
Sven De Vos
Consulting or Advisory Role - Bayer; Verastem
 
Ran Reshef
Consulting or Advisory Role - Atara Biotherapeutics; Celgene; Kite/Gilead; Magenta Therapeutics; Novartis; Pfizer
Research Funding - Adaptimmune (Inst); Atara Biotherapeutics (Inst); Bellicum Pharmaceuticals (Inst); Bluebird Bio (Inst); immatics (Inst); Incyte (Inst); Kite/Gilead (Inst); Pharmacyclics (Inst); Shire (Inst); Takeda (Inst); Tmunity Therapeutics, Inc. (Inst)
Expert Testimony - Monsanto
 
Lori A. Leslie
Honoraria - Abbvie/Pharmacyclics; ADC Therapeutics; BeiGene; Celgene; Janssen; Kite/Gilead; Seagen
Consulting or Advisory Role - Abbvie/Pharmacyclics; ADC Therapeutics; BeiGene; Celgene; Janssen; Kite/Gilead; Seagen
Speakers' Bureau - Abbvie/Pharmacyclics; ADC Therapeutics; BeiGene; Celgene; Janssen; Kite/Gilead; Seagen
 
Ibrahim Yakoub-Agha
Honoraria - Biotest; Celgene; Gilead Sciences; Janssen; Jazz Pharmaceuticals; Novartis
Travel, Accommodations, Expenses - Gilead Sciences
 
Olalekan O. Oluwole
Consulting or Advisory Role - Kite/Gilead; Pfizer
 
Henry C. Fung
Honoraria - Amgen; Janssen; Sanofi
 
Vicki Plaks
Employment - Kite/Gilead
Stock and Other Ownership Interests - Gilead Sciences
Travel, Accommodations, Expenses - Kite/Gilead
 
Yin Yang
Employment - Kite/Gilead
 
Jennifer Lee
Employment - Kite/Gilead
Stock and Other Ownership Interests - Gilead Sciences
 
Mauro P. Avanzi
Employment - Kite/Gilead
 
Sattva Swarup Neelapu
Honoraria - Aptitude Health; Bio Ascend; Medscape; MJH Life Sciences
Consulting or Advisory Role - Alimera Sciences; Celgene; Cell Medica; Gilead Sciences; Incyte; Kite, a Gilead company; Legend Biotech; Merck Sharp & Dohme; Novartis; Pfizer; Precision Biosciences; Unum Therapeutics
Research Funding - Acerta Pharma; Alimera Sciences; Bristol-Myers Squibb; Cellectis; Gilead Sciences; Karus Therapeutics; Kite, a Gilead company; Merck Sharp & Dohme; poseida therapeutics; Precision Biosciences; Unum Therapeutics
Patents, Royalties, Other Intellectual Property - Patents related to cellular therapy
Travel, Accommodations, Expenses - Alimera Sciences; Celgene; Chugai Pharma; Kite/Gilead; Legend Biotech; Medscape; Merck; Novartis; Pfizer; Precision Biosciences; Unum Therapeutics